Membranes for Homogeneous Catalyst Recovery Case Study Summary

As part of the Eternal project case study, AstraZeneca has developed a process using organic solvent nanofiltration (OSN) membrane technology to efficiently recover and reuse palladium catalysts during the synthesis of an important oncology drug. This minimizes energy consumption and waste production, promoting a more sustainable approach to catalyst management in pharmaceutical manufacturing. To further enhance sustainability, AstraZeneca is optimizing the OSN process by integrating solvent recovery techniques. They also aim to apply membranes to other pharmaceutical syntheses, which will broaden its impact and contribute to greener practices in industry.